16, 2013 July 15, 2013 - MD Anderson Cancer Center

16, 2013 July 15, 2013 - MD Anderson Cancer Center

HACETTEPE UNIVERSITY AND MD ANDERSON CANCER CENTER
WORKSHOP
JULY 15 -16, 2013
July 15, 2013 - Monday
9.00 – 9.15
Murat Tuncer MD, Professor, Rector of Hacettepe University
or
Kadri Altundağ MD, Professor, Director of Cancer Institute
Welcome – Opening Remarks
9.15 – 9.30
Karen Francis, MSc., MBA, Project Director, Global Academic
Programs (GAP)
Global Academic Programs and Collaborative Opportunities
George A. Calin, MD, PhD, Associate Professor, Experimental
9.30 – 10.15 Therapeutics (Keynote speaker)
NonCoding microRNA and cancer
10.15 - 10.45 Bülent Özpolat, MD, PhD, Assistant Professor, Experimental
Therapeutics
Development of siRNA-based novel gene therapies for cancer
10.45 – 11.00 Coffee break
Melih Babaoğlu, MD, Professor of Pharmacology
11.00 - 11.30 Pharmacogenomics research in Turkey
11.30 – 12.00 Ersin Fadıllıoğlu MD, Professor of Physiology
Cancer metabolic pathways
12.00 – 12.30 Brainstorming and round table discussion to form collaborations
12.30 – 1.30 Lunch
1.45 – 2.30
Banu Arun, MD, Professor, Breast Medical Oncology (Keynote speaker)
Integration of hereditary breast cancer and genetic testing into breast
cancer management as a multidisciplinary approach
2.30 – 3.00
3.00 – 3.30
3.30 – 3.45
3.45 – 4.15
4.15 - 4.45
4.45 - 5.15
5.15 – 6.00
Kadri Altundağ MD, Professor of Medical Oncology
Triple negative breast cancer
Mustafa Erman MD, PhD, Associate Professor
Mesothelioma
Coffee break
Dicle Güç MD, Professor of Basic Oncology
Tumor microenvironment in breast cancer
Güneş Esendağlı MD, PhD, Associate Professor
An adaptive immune escape mechanism in acute myeloid leukemia
Oral presentations
- S. Altuğ Kesikli MD, PhD
Monitorization of post-transplant endothelial complications
- A. Lale Doğan MD, PhD, Associate Professor of Basic Oncology
Regulation of FOXP1 by P13/Akt signaling pathway in breast cancer
Brainstorming and round table discussion to form collaborations
July 16, 2013 - Tuesday
Mehmet Doğan Aşık, MSc., PhD
Effects of ABCE1 and eRF3 siRNAs on (MCF7) breast cancer cell line
10.00 – 10.30 Aygin Ekincioğlu PhD, Associate Professor
Clinical pharmacy implications in oncology practice
Emir Baki Denkbaş PhD, Professor
10.30 – 11.00
Different based nanocarries for cancer therapy
11.00 – 11.30 Şebnem Harput PhD, Professor
Natural compounds as leads to anticancer agents: Clinical evaluations and
investigations
11.30 – 12.15 Brainstorming and round table discussion to form collaborations
12.15 – 1.30 Lunch
Nanomedicine and Cancer Session Chairs
- Gabriel Lopez - Berestein MD, Professor, Experimental Therapeutics
and
- Eylem Öztürk PhD, Associate Professor
1.45 – 2.30
Mustafa Selman Yavuz PhD, Associate Professor (Keynote speaker)
Nanomedicine applications in cancer
2.30 – 3.00
Eylem Öztürk PhD, Associate Professor
Polymeric nanoparticles for cancer therapy
3.00 – 3.15
Coffee break
3.15 – 3.45
Burcu Aslan, MSc., PhD Student
Targeting Zinc Finger Proteins in Ovarian Cancer
3.45 – 4.15
Gamze Torun Köse PhD, Professor
Tissue engineering applications
4.30 – 5.30
Brainstorming and round table discussion to form collaborations
Adjournment and Final Remarks
9.00 – 10.00